Intraarterial Thrombolysis Trials in Acute Ischemic Stroke

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 1 II, 2004, Pages

  Ng, Perry P ^a   Higashida, Randall T ^a   Cullen, Sean P ^a   Malek, Reza ^a   Dowd, Christopher F ^a   Halbach, Van V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; SARUPLASE; UROKINASE;

ACUTE DISEASE; BLEEDING; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; BRAIN PERFUSION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; FIBRINOLYTIC THERAPY; HEMATOMA; HUMAN; IMAGE ANALYSIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PERFORATION; PRIORITY JOURNAL; RECANALIZATION; RETROPERITONEAL HEMATOMA; REVIEW; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VERTEBRAL ARTERY;

EID: 1642539069     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rvi.0000107490.61085.10     Document Type: Review

References (60)

1. Chambers BR, Norris JW, Shurvell BL, Hachinski VC. Prognosis of acute stroke. Neurology 1987; 37:221-225.
2. Stroke- 1989. Recommendations on stroke prevention, diagnosis, and therapy: report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989; 20:1407-1431.
3. Wolf P, Kannel W, McGee D. Epidemiology of strokes in North America. In: Yatsu F, ed. Stroke: pathophysiology, diagnosis and management. New York, NY: Churchill Livingstone, 1986; 19-29.
4. Barnaby W. Stroke intervention. Emerg Med Clin North Am 1990; 8:267-280.
5. Dobbin B. The economic impact of stroke. Neurology 1995; 45(suppl 1):S10-14.
6. Saito I, Segawa H, Shiokawa Y, Taniguchi M, Tsutsumi K. Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome. Stroke 1987; 18:863-868.
7. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-1581.
8. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274:1017-1025.
9. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352:1245-1251.
10. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study - a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282:2019-2026.
11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
12. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study - a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282:2003-2011.
13. Lev MH, Farkas J, Rodriguez VR, et al. CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 2001; 25:520-528.
14. Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992; 23:317-324.
15. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999; 353:2036-2037.
16. Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999; 53:1528-1537.
17. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985; 312:932-936.
18. Pannell R, Gurewich V. Activation of plasminogen by single-chain urokinase or by two-chain urokinase: a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase). Blood 1987; 69:22-26.
19. Burke SE, Lubbers NL, Nelson RA, Henkin J. Recombinant pro-urokinase requires heparin for optimal clot lysis and restoration of blood flow in a canine femoral artery thrombosis model. Thromb Haemost 1993; 69:375-380.
20. Mani RL, Eisenberg RL. Complications of catheter cerebral arteriography: analysis of 5,000 procedures. III. Assessment of arteries injected, contrast medium used, duration of procedure, and age of patient. AJR Am J Roentgenol 1978; 131:871-874.
21. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis Scott Med J 1957; 2:200-215.
22. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 1993; 35:159-162.
23. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke: a review. II. Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging. Crit Care Med 2001; 29:1819-1825.
24. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994; 15:1817-1822.
25. Ezura M, Kagawa S. Selective and superselective infusion of urokinase for embolic stroke. Surg Neurol 1992; 38:353-358.
26. Gruber A, Nasel C, Lang W, Kitzmuller E, Bavinzski G, Czech T. Intra-arterial thrombolysis for the treatment of perioperative childhood cardioembolic stroke. Neurology 2000; 54:1684-1686.
27. Higashida RT, Halbach VV, Barnwell SL, Dowd CF, Hieshima GB. Thrombolytic therapy in acute stroke. J Endovasc Surg 1994; 1:4-15.
28. Higashida RT, Halbach VV, Tsai FY, Dowd CF, Hieshima GB. Interventional neurovascular techniques for cerebral revascularization in the treatment of stroke. AJR Am J Roentgenol 1994; 163:793-800.
29. Jungreis CA, Wechsler LR, Horton JA. Intracranial thrombolysis via a catheter embedded in the clot. Stroke 1989; 20:1578-1580.
30. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988; 19:802-812.
31. Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery 1995; 36:246-252; discussion 252-253.
32. Theron J, Courtheoux P, Casasco A, et al. Local intraarterial fibrinolysis in the carotid territory. AJNR Am J Neuroradiol 1989; 10:753-765.
33. Ueda T, Sakaki S, Kumon Y, Ohta S. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999; 30:2360-2365.
34. del Zoppo GJ, Ferbert A, Otis S, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 1988; 19:307-313.
35. Jansen O, von Kummer R, Forsting M, Hacke W, Sartor K. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 1995; 16:1977-1986.
36. Zeumer H. Vascular recanalizing techniques in interventional neuroradiology. J Neurol 1985; 231:287-294.
37. Tanahashi N, Fukuuchi Y. Treatment of acute ischemic stroke: recent progress. Intern Med 2002; 41:337-344.
38. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators Prolyse in Acute Cerebral Thromboembolism Stroke 1998; 29:4-11.
39. Mahoney F, Barthel D. Functional evaluation: the Barthel index. Md Med J 1965; 14:61-65.
40. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001; 57:1603-1610.
41. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30:2598-2605.
42. Tomsick T, Broderick J, Pancioli A, et al. Combined IV-IA rtPA treatment in major ischemic stroke (abstr). Stroke 2002; 33:359.
43. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2001; 22:352-358.
44. Lee DH, Jo KD, Kim HG, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 2002; 13:769-774.
45. Bruckmann H, Ferbert A, del Zoppo GJ, Hacke W, Zeumer H. Acute vertebral-basilar thrombosis: angiologicclinical comparison and therapeutic implications. Acta Radiol Suppl 1986; 369:38-42.
46. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19:1216-1222.
47. Becker KJ, Monsein LH, Ulatowski J, Mirski M, Williams M, Hanley DF. Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR Am J Neuroradiol 1996; 17:255-262.
48. Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 1996; 27:875-881.
49. Fox T, Hamann G, Strittmatter M. Local intraarterial fibrinolysis in vertebrobasilar thrombosis: prognostic criteria (abstr). Cerebrovasc Dis 1996; 6:188.
50. Matsumoto K, Satoh K. Intraarterial therapy in ischemic stroke. In: Mori E, ed. Thrombolytic therapy in acute ischemic stroke III. Tokyo, Japan: Springer-Verlag 1995; 279-287.
51. Clark W, Barnwell SL, Nesbit G. Efficacy of intra-arterial thrombolysis of basilar artery stroke (abstr). J Stroke Cerebrovasc Dis 1997; 6:457.
52. Cross DT III, Moran CJ, Akins PT, Angtuaco EE, Diringer MN. Relationship between clot location and outcome after basilar artery thrombolysis. AJNR Am J Neuroradiol 1997; 18:1221-1228.
53. Zeumer H, Freitag HJ, Grzyska U, Neunzig HP. Local intraarterial fibrinolysis in acute vertebrobasilar occlusion: technical developments and recent results. Neuroradiology 1989; 31:336-340.
54. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:78-86.
55. Pessin M, del Zoppo GJ, Furlan A. Thrombolytic treatment in acute stroke: review and update of specific topics. In: Caplan L, ed. Cerebrovascular diseases: Nineteenth Princeton Stroke Conference. Boston Mass: Butterworth-Heinemann 1995; 409-418.
56. Katzan IL, Masaryk TJ, Furlan AJ, et al. Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 1999; 52:1081-1084.
57. Jahan R, Duckwiler GR, Kidwell CS, et al. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol 1999; 20:1291-1299.
58. Endo S, Kuwayama N, Hirashima Y, Akai T, Nishijima M, Takaku A. Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery. AJNR Am J Neuroradiol 1998; 19:1169-1175.
59. Herderschee D, Limburg M, van Royen EA, Hijdra A, Buller HR, Koster PA. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT. Acta Neurol Scand 1991; 83:317-322.
60. Grotta JC, Alexandrov AV. tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke 1998; 29:429-432.